Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

22 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Octapharma Articles

FDA approves CSL's Kcentra and accepts Octapharma Octaplex BLA for reversal of anticoagulation

30 April 2013

FDA approves Protein Sciences egg-free flu vaccine Flublok; and Octapharma's Octaplas

18 January 2013

News briefs: AstraZeneca suspends share repurchasing; New CMO for Sanofi; Research facility for Octapharma

2 October 2012

European Commission to lift suspension of Octapharma MA for Octagam

1 June 2011

European Medicines Agency unit says Octagam suspension should be lifted

15 April 2011

Positive CHMP opinions for AstraZeneca and Novartis, but suspension of Octapharma’s Octagam called for; Roche Avastin review

26 September 2010

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Is failure to adopt business process management putting the pharma industry at risk?
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Is failure to adopt business process management putting the pharma industry at risk?
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS